Abpro Holdings, Inc Common Stock (ABP)

• Market cap: $79.9M
• 1 day: -27.23%
• 5 days: -40.61%
• 1 month: -58.22%
• 3 months: -58.22%
• 6 months: -58.22%
• Year to date: -58.22%
• 1 year: -58.22%
• 5 years: -58.22%
• 10 years: -58.22%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.